These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34028533)

  • 41. Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog.
    Qi XY; Diness JG; Brundel BJ; Zhou XB; Naud P; Wu CT; Huang H; Harada M; Aflaki M; Dobrev D; Grunnet M; Nattel S
    Circulation; 2014 Jan; 129(4):430-40. PubMed ID: 24190961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Termination of aconitine-induced atrial fibrillation by the KACh-channel blocker tertiapin: underlying electrophysiological mechanism.
    Suzuki K; Matsumoto A; Nishida H; Reien Y; Maruyama H; Nakaya H
    J Pharmacol Sci; 2014; 125(4):406-14. PubMed ID: 25030741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of selective I
    Fenner MF; Carstensen H; Dalgas Nissen S; Melis Hesselkilde E; Scott Lunddahl C; Adler Hess Jensen M; Loft-Andersen AV; Sattler SM; Platonov P; El-Haou S; Jackson C; Tang R; Kirby R; Ford J; Schotten U; Milnes J; Svane Sørensen U; Jespersen T; Buhl R
    Br J Pharmacol; 2020 Aug; 177(16):3778-3794. PubMed ID: 32436234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An N-/L-type calcium channel blocker, cilnidipine, suppresses autonomic, electrical, and structural remodelling associated with atrial fibrillation.
    Tajiri K; Guichard JB; Qi X; Xiong F; Naud P; Tardif JC; Costa AD; Aonuma K; Nattel S
    Cardiovasc Res; 2019 Dec; 115(14):1975-1985. PubMed ID: 31119260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can inhibition of IKur promote atrial fibrillation?
    Burashnikov A; Antzelevitch C
    Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TREK-1 (K
    Lugenbiel P; Wenz F; Syren P; Geschwill P; Govorov K; Seyler C; Frank D; Schweizer PA; Franke J; Weis T; Bruehl C; Schmack B; Ruhparwar A; Karck M; Frey N; Katus HA; Thomas D
    Basic Res Cardiol; 2017 Jan; 112(1):8. PubMed ID: 28005193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of I
    Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety.
    Li D; Sun H; Levesque P
    Cardiovasc Hematol Agents Med Chem; 2009 Jan; 7(1):64-75. PubMed ID: 19149545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule.
    Takemoto Y; Slough DP; Meinke G; Katnik C; Graziano ZA; Chidipi B; Reiser M; Alhadidy MM; Ramirez R; Salvador-Montañés O; Ennis S; Guerrero-Serna G; Haburcak M; Diehl C; Cuevas J; Jalife J; Bohm A; Lin YS; Noujaim SF
    FASEB J; 2018 Apr; 32(4):1778-1793. PubMed ID: 29162702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels.
    Ratte A; Wiedmann F; Kraft M; Katus HA; Schmidt C
    Front Pharmacol; 2019; 10():1367. PubMed ID: 32038227
    [No Abstract]   [Full Text] [Related]  

  • 51. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
    Tsujimae K; Murakami S; Kurachi Y
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.
    Walfridsson H; Anfinsen OG; Berggren A; Frison L; Jensen S; Linhardt G; Nordkam AC; Sundqvist M; Carlsson L
    Europace; 2015 Mar; 17(3):473-82. PubMed ID: 25082948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
    Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation.
    Machida T; Hashimoto N; Kuwahara I; Ogino Y; Matsuura J; Yamamoto W; Itano Y; Zamma A; Matsumoto R; Kamon J; Kobayashi T; Ishiwata N; Yamashita T; Ogura T; Nakaya H
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):94-102. PubMed ID: 21156770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium.
    Skibsbye L; Wang X; Axelsen LN; Bomholtz SH; Nielsen MS; Grunnet M; Bentzen BH; Jespersen T
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):165-76. PubMed ID: 25856531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition.
    Diness JG; Skibsbye L; Jespersen T; Bartels ED; Sørensen US; Hansen RS; Grunnet M
    Hypertension; 2011 Jun; 57(6):1129-35. PubMed ID: 21502564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel ion channel targets in atrial fibrillation.
    Hancox JC; James AF; Marrion NV; Zhang H; Thomas D
    Expert Opin Ther Targets; 2016 Aug; 20(8):947-58. PubMed ID: 26918581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiological effects of ranolazine in a goat model of lone atrial fibrillation.
    Opačić D; van Hunnik A; Zeemering S; Dhalla A; Belardinelli L; Schotten U; Verheule S
    Heart Rhythm; 2021 Apr; 18(4):615-622. PubMed ID: 33232809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Na+-channel blockade on the three-dimensional substrate of atrial fibrillation in a model of endo-epicardial dissociation and transmural conduction.
    Gharaviri A; Verheule S; Eckstein J; Potse M; Krause R; Auricchio A; Kuijpers NHL; Schotten U
    Europace; 2018 Nov; 20(suppl_3):iii69-iii76. PubMed ID: 30476060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.